More Recce Pharmaceuticals Ltd. news
Recce Pharmaceuticals Ltd.ASX: RCE

USA Patent Granted for Recces Antibiotics

Mar 13, 2019 at 11:47 PM EDT · Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · Mar 13, 2019 at 11:47 PM EDT · 1 page · English

On 6ix: 6ix.com/news/usa-patent-granted-for-recces-antibiotics

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

  • Recce Successfully Raises $1.8 million via PlacementFeb 7, 2019
  • Change of Registry Address: Automic P/L - Sydney OfficeSep 28, 2018
  • Key Australian Patent for Recces Broad-Spectrum AntibioticsJul 31, 2018
  • Update on Progress of Broad Spectrum Antibiotic RECCE 327Jul 18, 2018
  • Update on meeting with US FDAJun 5, 2018

Later from Recce Pharmaceuticals

  • Appointment of Independent Chair and Additional DirectorJul 9, 2019
  • Appendix 4C and commentaryJul 30, 2019
  • Opening R&D Address at World Antibiotic Resistance CongressJul 31, 2019
  • Key Family 2 Patent Granted in Europe for RECCE AntibioticsAug 8, 2019
  • Response to ASX Appendix 4C QueryAug 16, 2019
All Recce Pharmaceuticals news releases↗

Follow Recce Pharmaceuticals into a list and get an email when it puts out news.

Follow Recce Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer